{"entity":{"id":"paxman","kind":"company","name":"Paxman","aka":[],"tldr":"Paxman is the British maker of the Paxman Scalp Cooling System, a chilled cap worn during chemotherapy to reduce hair loss, cleared in the United States in 2017 and used in cancer centres across the world.","summary":"Paxman, based in Huddersfield and listed on London's AIM market, developed its refrigerated scalp cooling system from the family's drinks-cooling business after a relative's chemotherapy. The system was cleared by the FDA in 2017 for breast cancer and later for solid tumours, and the company is developing cooling for chemotherapy-induced neuropathy.","asOf":"2026-09-17","links":[{"label":"Official website","url":"https://paxmanscalpcooling.com/"},{"label":"Paper: SCALP randomised trial (JAMA 2017)","url":"https://doi.org/10.1001/jama.2016.20939"}],"tags":["machines-wave2"],"related":[],"cancers":["breast-cancer"],"sections":[],"technologies":["scalp-cooling","cytotoxic-chemotherapy"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Huddersfield","country":"GB","companyType":"devices","website":"https://paxmanscalpcooling.com/","ticker":"PAX","stage":"public","investors":[],"funding":[]},"route":"/companies/paxman/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"}],"technology":[{"id":"cytotoxic-chemotherapy","kind":"technology","name":"Cytotoxic chemotherapy","route":"/technologies/cytotoxic-chemotherapy/"},{"id":"scalp-cooling","kind":"technology","name":"Scalp cooling (cold caps: DigniCap, Paxman)","route":"/technologies/scalp-cooling/"}]}}